share_log

Neumora Therapeutics | 8-K: Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

SEC announcement ·  May 7 07:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more